http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2362279-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_408a673e5f3674e77d63dfe2a7856215
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2000-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cacac742723cce6bfce7ae32d198a26d
publicationDate 2000-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2362279-A1
titleOfInvention Connective tissue softening
abstract The use of Matrix Metalloproteinase Inhibitors, like galardin or batimsatat in the prevention or treatment of connective tissue softening in particular tendon injuring and also for the maintenance of sutures in such connective tissues. The connective tissue may be a tendon, ligament or cartilage.</SDOA B>
priorityDate 1999-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21857
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362422
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403816
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396862
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41248
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID116510

Total number of triples: 26.